Health Economics

• 10th Nov 2025

  Preferences for advanced therapy medicinal products: understanding the published literature on the value of innovative health interventions

• 23rd Jun 2025

  The value of hope – the case against inclusion in a value assessment framework for advanced therapies 

• 2nd Sep 2024

  A case study of the challenges of demonstrating cost-effectiveness in under-served patient populations: lecanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer’s disease

• 1st Sep 2022

  Key Questions on the Development of Health Economics